CommercialCoverageMedium impact
08.02.38, Zenocutuzumab-zbco (Bizengri®)
Independence Blue Cross·Oncology, Hematology·Pharmacy
Effective date
Jul 28, 2025
We identified it
Jun 19, 2026
Summary
A new policy has been established for Zenocutuzumab-zbco (Bizengri®), a specialty pharmacy medication. This new drug coverage policy will define coverage criteria, billing requirements, and potential prior authorization needs for this recently approved medication.
Action Required
By July 28, 2025: Billing team must review the full policy details at the provided URL to understand coverage criteria, prior authorization requirements, and billing procedures for Zenocutuzumab-zbco (Bizengri®). Update billing system and prior authorization workflows as specified in the complete policy document.